- Home
- UNTY vs MREO Comparison
UNTY vs MREO Comparison
Compare UNTY & MREO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UNTY
- MREO
- Stock Information
- Founded
- UNTY 1991
- MREO 2015
- Country
- UNTY United States
- MREO United Kingdom
- Employees
- UNTY N/A
- MREO N/A
- Industry
- UNTY Major Banks
- MREO Biotechnology: Pharmaceutical Preparations
- Sector
- UNTY Finance
- MREO Health Care
- Exchange
- UNTY Nasdaq
- MREO Nasdaq
- Market Cap
- UNTY 458.0M
- MREO 438.8M
- IPO Year
- UNTY 1997
- MREO N/A
- Fundamental
- Price
- UNTY $51.75
- MREO $1.74
- Analyst Decision
- UNTY Buy
- MREO Strong Buy
- Analyst Count
- UNTY 3
- MREO 5
- Target Price
- UNTY $56.00
- MREO $7.40
- AVG Volume (30 Days)
- UNTY 45.7K
- MREO 1.4M
- Earning Date
- UNTY 10-10-2025
- MREO 08-12-2025
- Dividend Yield
- UNTY 1.08%
- MREO N/A
- EPS Growth
- UNTY 30.37
- MREO N/A
- EPS
- UNTY 4.94
- MREO N/A
- Revenue
- UNTY $116,265,000.00
- MREO $500,000.00
- Revenue This Year
- UNTY $23.79
- MREO N/A
- Revenue Next Year
- UNTY $9.20
- MREO $55.50
- P/E Ratio
- UNTY $10.52
- MREO N/A
- Revenue Growth
- UNTY 17.14
- MREO N/A
- 52 Week Low
- UNTY $31.44
- MREO $1.47
- 52 Week High
- UNTY $54.64
- MREO $4.95
- Technical
- Relative Strength Index (RSI)
- UNTY 62.05
- MREO 47.94
- Support Level
- UNTY $48.05
- MREO $1.64
- Resistance Level
- UNTY $49.40
- MREO $1.78
- Average True Range (ATR)
- UNTY 1.28
- MREO 0.09
- MACD
- UNTY 0.35
- MREO 0.04
- Stochastic Oscillator
- UNTY 86.27
- MREO 77.14
About UNTY Unity Bancorp Inc.
Unity Bancorp Inc is a bank holding company that serves as a holding company for Unity Bank. It conducts a traditional and community-oriented commercial banking business and offers services, including personal and business checking accounts, time deposits, money market accounts, regular savings accounts, and others. The company structures its specific services and charges in a manner designed to attract the business of small and medium-sized businesses and professional communities, as well as individuals residing, working, and shopping in its service area. The company engages in a wide range of lending activities and offers commercial, Small Business Administration, consumer, mortgage, home equity, and personal loans.
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).